Literature DB >> 27042970

Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome.

Laura C Torchen1, Ajay Kumar2, Bhanu Kalra2, Gopal Savjani2, Ryan Sisk3, Richard S Legro4, Andrea Dunaif5.   

Abstract

OBJECTIVE: To investigate for differences in reproductive hormone levels in male relatives of women with polycystic ovary syndrome (PCOS).
DESIGN: Cross-sectional study.
SETTING: Academic medical center. PATIENT(S): Sixty-three fathers and 66 brothers of women with PCOS as well as two groups of control men of comparable age to fathers (older control, n = 30) and brothers (younger control, n = 58). INTERVENTION(S): A single early morning fasting blood sample was obtained for the measurement of reproductive hormone levels. MAIN OUTCOME MEASURE(S): Testosterone, LH, FSH, antimüllerian hormone (AMH), inhibin B, estradiol (E2), and estrone (E1) levels were measured. RESULT(S): The AMH, LH, and FSH levels were significantly increased in male relatives compared with their respective control groups. The levels of E2, E1, T, and inhibin B did not differ between the groups. CONCLUSION(S): The AMH, LH, and FSH levels were increased in adult male relatives of women with PCOS, suggesting that they may have altered testicular function and changes in neuroendocrine regulation of gonadotropin secretion. These changes may reflect effects of PCOS susceptibility genes such as the recently mapped chromosome 11p14.1 locus in the region of the FSH B polypeptide gene.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Polycystic ovary syndrome; antimüllerian hormone; first degree relatives; gonadotropins

Mesh:

Substances:

Year:  2016        PMID: 27042970      PMCID: PMC4930891          DOI: 10.1016/j.fertnstert.2016.03.029

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  43 in total

1.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

2.  International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values.

Authors:  H E Solberg
Journal:  J Clin Chem Clin Biochem       Date:  1987-05

3.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Authors:  Uche Ezeh; Bulent O Yildiz; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

Review 4.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

5.  A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay.

Authors:  Paul Welsh; Karen Smith; Scott M Nelson
Journal:  Hum Reprod       Date:  2014-02-26       Impact factor: 6.918

6.  Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.

Authors:  R J Santen; C W Bardin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

7.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

Authors:  Pascal Pigny; Emilie Merlen; Yann Robert; Christine Cortet-Rudelli; Christine Decanter; Sophie Jonard; Didier Dewailly
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

8.  Metabolic profile in sons of women with polycystic ovary syndrome.

Authors:  Sergio E Recabarren; Rosita Smith; Rafael Rios; Manuel Maliqueo; Bárbara Echiburú; Ethel Codner; Fernando Cassorla; Pedro Rojas; Teresa Sir-Petermann
Journal:  J Clin Endocrinol Metab       Date:  2008-01-29       Impact factor: 5.958

9.  Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.

Authors:  Irene Cimino; Filippo Casoni; Xinhuai Liu; Andrea Messina; Jyoti Parkash; Soazik P Jamin; Sophie Catteau-Jonard; Francis Collier; Marc Baroncini; Didier Dewailly; Pascal Pigny; Mel Prescott; Rebecca Campbell; Allan E Herbison; Vincent Prevot; Paolo Giacobini
Journal:  Nat Commun       Date:  2016-01-12       Impact factor: 14.919

10.  Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.

Authors:  M Geoffrey Hayes; Margrit Urbanek; David A Ehrmann; Loren L Armstrong; Ji Young Lee; Ryan Sisk; Tugce Karaderi; Thomas M Barber; Mark I McCarthy; Stephen Franks; Cecilia M Lindgren; Corrine K Welt; Evanthia Diamanti-Kandarakis; Dimitrios Panidis; Mark O Goodarzi; Ricardo Azziz; Yi Zhang; Roland G James; Michael Olivier; Ahmed H Kissebah; Elisabet Stener-Victorin; Richard S Legro; Andrea Dunaif
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

View more
  9 in total

Review 1.  Does a male polycystic ovarian syndrome equivalent exist?

Authors:  R Cannarella; R A Condorelli; L M Mongioì; S La Vignera; A E Calogero
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

2.  Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.

Authors:  Lidija K Gorsic; Gulum Kosova; Brian Werstein; Ryan Sisk; Richard S Legro; M Geoffrey Hayes; Jose M Teixeira; Andrea Dunaif; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

3.  Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome.

Authors:  Matthew Dapas; Ryan Sisk; Richard S Legro; Margrit Urbanek; Andrea Dunaif; M Geoffrey Hayes
Journal:  J Clin Endocrinol Metab       Date:  2019-04-30       Impact factor: 5.958

4.  Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.

Authors:  Lidija K Gorsic; Matthew Dapas; Richard S Legro; M Geoffrey Hayes; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

Review 5.  Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment.

Authors:  Elisabet Stener-Victorin; Qiaolin Deng
Journal:  Nat Rev Endocrinol       Date:  2021-07-07       Impact factor: 43.330

6.  Associations of Maternal Androgen-Related Conditions With Risk of Autism Spectrum Disorder in Progeny and Mediation by Cardiovascular, Metabolic, and Fertility Factors.

Authors:  Ran S Rotem; Vy T Nguyen; Gabriel Chodick; Michael Davidovitch; Varda Shalev; Russ Hauser; Brent A Coull; Andrea Bellavia; Marc G Weisskopf
Journal:  Am J Epidemiol       Date:  2021-04-06       Impact factor: 4.897

7.  The influence of maternal androgen excess on the male reproductive axis.

Authors:  Sarah Holland; Melanie Prescott; Michael Pankhurst; Rebecca E Campbell
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

8.  Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?

Authors:  Rossella Cannarella; Rosita A Condorelli; Federica Dall'Oglio; Sandro La Vignera; Laura M Mongioì; Giuseppe Micali; Aldo E Calogero
Journal:  Int J Endocrinol       Date:  2020-02-12       Impact factor: 3.257

Review 9.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions.

Authors:  Antonio Aversa; Sandro La Vignera; Rocco Rago; Alessandra Gambineri; Rossella E Nappi; Aldo E Calogero; Alberto Ferlin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.